Unraveling Amentoflavone's Therapeutic Potential in Alzheimer's Disease: A Preclinical Assessment.

Comb Chem High Throughput Screen

Institute of Pharmaceutical Research, GLA University, Mathura, 281406, U.P., India.

Published: July 2024

Alzheimer's disease is one of the neurodegenerative diseases which causes cognition deficit. There are currently few medications available to treat Alzheimer's disease, even though researchers have devoted a great deal of time studying the condition and offering many benefits. Thus, only a few drugs are available for the treatment of Alzheimer's disease. Amentoflavone is a dietary component found in many plants and herbs that has several health advantages. Amentoflavone has demonstrated strong protective benefits against a range of brain illnesses in preclinical trials, most frequently in Alzheimer's disease. Amentoflavone, a biflavonoid, can be identified in a variety of herbs upon isolation. Considering the beneficial properties of this compound, this review emphasizes the pharmacological effects and botanical sources of amentoflavone, as well as the compound's benefits and possible applications in the treatment of Alzheimer's disorders.

Download full-text PDF

Source
http://dx.doi.org/10.2174/0113862073301291240229102657DOI Listing

Publication Analysis

Top Keywords

alzheimer's disease
20
treatment alzheimer's
8
disease amentoflavone
8
alzheimer's
6
disease
5
unraveling amentoflavone's
4
amentoflavone's therapeutic
4
therapeutic potential
4
potential alzheimer's
4
disease preclinical
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!